Anti-Doping Activities

The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from a grantee to provide continued support of anti-doping efforts to educate athletes on the dangers of drug use and eliminate doping in amateur athletic competitions recognized by the United States Olympic Committee. Specifically: 1) Provide continued support of anti-doping efforts to educate athletes on the dangers of drug use and eliminate doping in amateur athletic competitions recognized by the United States Olympic Committee; 2) Provide support for athlete drug testing programs, research initiatives, educational programs and efforts to inform athletes of the adopted rules governing the use of prohibited substances outlined in the World Anti-Doping Code (the Code); and 3) Provide support for legal efforts to enforce compliance with the Code and adjudicate athlete appeals involving doping violations.

Applicant must be able to serve as the United States representatives responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the United States Olympic and Paralympic Committee. Applicant must be recognized by the United States Olympic and Paralympic Committee as the official anti- doping agency for the United States. Applicants must also ensure compliance with all federal laws, regulations, Executive Orders, and public policies governing financial assistance awards.

Applicants must demonstrate the organization�s expert knowledge and extensive experience in anti-doping requirements, techniques, and application of programs to determine compliance. Applicants must be recognized or be acceptable by the United States Olympic Committee.

Match: none required (federal program listing). Statutory Formula: Title 2, Part 3603, Subpart 1,Public Law P.L. 109-469.Authority: 21 U.S.C. 1706; 21 U.S.C. 1703(d), 1703(f), 21 U.S.C. 1701, 21 U.S.C. 1521-1548, 21 U.S.C. 2001-2003, Office of National Drug Control Policy Reauthorization Act of 2006, P.L 109-469 (2006), 2 CFR part 200. Source: 79 FR 76105, Dec. 19, 2014, unless otherwise noted. � 3603.1 Adoption of 2 CFR Part 200. Under the authority listed above, the Executive Office of the President, Office of National Drug Control Policy (ONDCP) adopts the Office of Management and Budget (OMB) Guidance in 2 CFR part 200. Thus, this part gives regulatory effect to the OMB guidance and supplements the guidance as needed for ONDCP.